Effect of aqueous and ethanolic extracts of Lippia citriodora on candida albicans
Keywords:
Anti-Candida albicans activity, Lippia citriodora, Ethanolic and Aqeoues extracts, Nystatin, FluconazoleAbstract
Introduction: Because of resistance and side effects to common antifungal drugs activity, the research on herbal substances with antifungal activity is frequent. Lemon verbena (Lippia citriodora) is a member of Verbenaceae family. The aim of this study was to determine the anti-candida activities of the ethanolic and aqueous extracts of the lemon verbena leaves and compare them with nystatin and fluconazole.
Methods: In this 2015 study, 15 clinical isolates and standard strain of candida albicans PTCC 5027 were used, and the inhibitory effects of the ethanolic and aqueous extracts, Nystatin and Fluconazole, were evaluated using disk and well diffusion methods. Also, the minimal inhibitory concentration (MIC) was determined. Five concentrations of aqueous and ethanolic extracts (156-2500 μg/ml), Nystatin (8-128 μg/ml) and Fluconazole (4-64 μg/ml) were used in disk and well diffusion methods, and nine concentrations of aqueous and ethanolic extracts (19-5000 μg/ml), Nystatin (0.5-128 μg/ml), and Fluconazole (0.25-64 μg/ml) were applied for MIC. Data were analyzed using Tukey's post-hoc and one-way ANOVA tests. The significant level was considered p < 0.05 in the current study.
Results: In the well and disk diffusion techniques, limited growth inhibition halos were produced around some clinical isolates at different concentrations of ethanolic extract; however, no growth inhibitory halo was observed with any concentrations of the aqueous extract. The MIC values of ethanolic extract, aqueous extract, Nystatin and Fluconazole for clinical isolated and standard strain were 833 ± 78.5and 625μg/ml; 4156 ± 67.4 and 2500 μg/ml; 10.13 ± 1.91 and 4 μg/ml; and 1.97 ± 0.25 and 1 μg/ml, respectively.
Conclusion: The results showed that the ethanolic extract was stronger than the aqueous extract of this plant, which can be used as an alternative for drugs. It is recommended that the ethanolic extract of this plant be investigated in vivo for better evaluation of its efficacy and properties.
References
Neville BW, Damm OD, Allen CM, Bouquot JE. Oral and Maxillofacial Pathology. 3th ed. Elsevier
Sunders; 2009, ch6 : 213-8.
Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbial. 2011; 3(10): 3402- 7. doi: 10.3402/jom.v3i0.5771.
Raja M, Hannan A, Ali K. Association of oral candida carriage with dental caries in children. Caries
Res. 2010; 44(3): 272-6. doi: 10.1159/000314675, PMID: 20516688.
Silva DS, Cavalho FC, Hebling J. Presence of mutants streptococci and candida spp. In dental
plaque/dentin of carious teeth and early child hood caries. Caries Res. 2006; 51(11): 1024-8. doi:
1016/j.archoralbio.2006.06.001, PMID: 16890907.
Pina-Vaz C, Rodrigues AG, Pinto E, Costa-de-oliveira S, Tavares C, Salgueiro L, et al. Antifungal activity
of Thymus oils and their major compunds. J Eur Acad Dermatol. 2004; 18(1): 73-8. doi: 10.1111/j.1468- 3083.2004.00886.x, PMID: 14678536.
Zarei Mahmoudabadi A, Antifungal drugs. First ed. Ahwaz. Medical Sciences University of Ahwaz Pub.
Persian.
Abderrahim F, Estrella S, Susin C, Arribas SM, González MC, Condezo-Hoyos L. The antioxidant activity
and stability of lemon verbena infusion. J Med Food. 2011; 14(5): 517-27. doi: 10.1089/jmf.2010.0102,
PMID:21434775.
Mothana RAA, Abdo SA, Hasson S, Althawab FM, Alaghbari SA, Lindequist U. Antimicrobial,
antioxidant and cytotoxic activities and phytochemical screening of some Yemeni medicinal plants. Evid
Based Complement Alternat Med. 2010; 7(3): 323–30. doi: 10.1093/ecam/nen004, PMID: 18955315.
PMCID: PMC2887327
Chavallier A. The Encyclopedia of medicinal plants, Dorling Kinderseley. London. 1996; p 227.
Santos G, fernandes F. Composition of the essential oils from flowers and leaves of vervain. J Essent Oil
Res. 2005; 17(1): 73-7. doi: 10.1080/10412905.2005.9698835.
Pastorelli G, Rossi R, Corino C. Influence of lippia citriodora verbacoside on growth performance,
antioxidant status, and serum immunoglobulins content in piglets. Czech J Anim Sci. 2012; (7): 312-22.
Valenta˜o P, Fernandes E, Carvalho F, Andrade PB, Seabra RM, de Lourdes Basto M. Studies on the
antioxidant activity of Lippia citriodora infusion: scavenging effect on superoxide radical, hydroxyl radical
and hypochlorous acid. Biol Pharm Bull. 2002; 25: 1324–7. doi: 10.1248/bpb.25.1324.
Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. Int J antimicrobial agents. 2005; 26(5): 343–
doi: 10.1093/ecam/nen004, PMID: 18955315.
Koohsari H, Ghaemi EA, sheshpoli M, Sadegh A. Evaluation of antibacterial activity of Lemon verbena
leaves. Ann Bio Res. 2013; 4(10): 52-5.
Clinical And Laboratory Standatds Institutes. Refrence Method for Broth Dilution Antifungal
Susceptibility Testing of Yeasts; Approved Standard-Third Edition. M27-A3. 2008; 28(14).
Valentao P, Fernandes E, Carvalho H. Studies on the antioxidant activity of lippiacitriodora infusion:
scavenging effects on superoxide radical, hydroxyl radical and hypochlorus acid. Biol Pharm Bull. 2002;
(10): 1324-1327. doi: 10.1248/bpb.25.1320, PMID: 12392087.
Choupani M, Arabsha S, Delouee I, Alami M. Antioxidant Properties of Various Solvent Extracts of
Lemon Verbena (LippiaCitriodora) Leaves. Int j AdvanBiol and Biomed Res. 2014; 2(4): 1340-6.
Carnat A, Carnat AP, Chavignon O, Heitz A, Wylde R, Lamaison JL. Luteolin 7-diglucuronid, the major
flavonoid compound from Aloysiatriphylla and Verbena officinalis. Planta Med. 1995; 61(5): 490-1. doi:
1055/s-2006-958152, PMID: 7480218.
Marzuk Z, Marzuk B, chraief I, Boukef K. Analysis of Tunisian Menthapulegium L. oils from Monastir.
SIPAM. 2006.
Oskay M, Usame Tamer A, Gungor AY, Sari D, Aktas K. Antimicrobial Activity of the Leaves of Lippia
triphylla O. Kuntze (Verbenaceae) Against on Bacteria and Yeasts. J Biol Scien J. 2005; 5(5): 620-2. doi:
3923/jbs.2005.620.622.
Cowan MM. Plant products as antimicrobial agents. Clinical Microbiol Rev. 1999; 12: 564-82. PMID:
, PMCID: PMC88925.
Lozada BS, Viviana Herrera L, Perea JA, Stanshenko E, Escobar P. In vitro effect of essential oils of three
Lippia species on Moniliophthora roreri (Cif. and Par.) causative agent of moniliasis of cocoa. Acta Agron.
; 61(2): 94-102.
Ohno T, Kita M, Yamaoka Y, Imamura S, Yamamoto T, Mitsufuji S, et al. Antimicrobial activity of
essential oils against Helicobacter pylori. Helicobacter. 2003; 8: 207–15. doi: 10.1046/j.1523- 5378.2003.00146.x, PMID: 12752733.
Ramzi AA, Mothana Salah AA, AbdoSidgi H, Faisal MN, AlthawabSama AZ. Antimicrobial, Antioxidant
and Cytotoxic Activities and phytochemical screening of some Yemeni medicinal plants. Act Screen
Yemeni Med Plant. 2010; 7(3): 323-30.
Ansari M, Larijani K, Tehrani MS. Antibacterial activity of Lippa citriodora herb essence against MRSA
Staphylococcus aureaus. AJMR. 2012; 6: 16-9.
Tatsadjieu NL, Jazet Dongmo PM, Nagssoum MB, Etoac FX, Mbofung CMF. Investigations on the
essential oil of Lippiarugosa from Cameroon for its potential use as antifungal agent against Aspergillus
flavus ex Fries. Food Control. 2009; 20(2): 161-6. doi: 10.1016/j.foodcont.2008.03.008.
Correa-Royero J, Tangarife V, Duran C. Invitro antifungal activity and cytotoxic effect of essential oils and
extracts of medicinal and aromatic plants against Candida Krusei and Aspergillus fumigatus. Braz J Pharm.
; 20(5): 734-41.
Oliveira DR, Leitao GG, Bizzo HR, Lopes D, Alviano DS, Alviano CS, Leitao SG. Chemical and
Antimicrobial analyses of essential oil of Lippia origanoides H.B.K. Food Chemistry. 2007; 101: 236-240,
doi: 10.1016/j.foodchem.2006.01.022.
Viollon C, Chaumont JP. Antifungal properties of essential oils and their main components upon
Cryptococcus neoformans. Mycopathologia. 1994; 128: 151-3. PMID: 7739729.
Pascual ME, Slowing K, Carretero E, Sanchez D, Mata D, Villar A. Lippia: traditional uses, chemistry and
pharmacology: a review. J Ethnopharmacol. 2001; 76: 201-14. PMID: 11448540.
Santoro A, Bianco G, Picerno P, Aquino RP, Autore G, Marzocco S, et al. Verminoside- and Verbacosideinduced genotoxicity on human lymphocytes: Involvment of PARP1 and P53 proteins. Toxicolo let. 2008;
(2): 71-6. doi: 10.1016/j.toxlet 2008.02.006, PMID: 18395372.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
